Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment
- PMID: 15956166
- DOI: 10.1001/archneur.62.6.953
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment
Abstract
Background: Subjects with mild cognitive impairment (MCI) have been shown to have reduced hippocampal volumes relative to normal elderly control subjects. The presence of the apolipoprotein E epsilon4 (APOE*E4) allele has been associated with greater hippocampal atrophy in women than in men with Alzheimer disease. This relationship has not been demonstrated in MCI.
Objective: To examine the relationship between APOE genotype and hippocampal volume in men and women with MCI.
Design: This study evaluated MCI in 193 subjects (86 women and 107 men) participating in a multicenter clinical trial, all of whom underwent magnetic resonance imaging at their baseline visit. We evaluated the association among the number of APOE*E4 alleles, memory performance, and hippocampal volume in men and women with tests of means and multiple linear regressions.
Results: Compared with MCI subjects with no APOE*E4 alleles, women with 1 or 2 APOE*E4 alleles were found to have significantly reduced hippocampal volume, whereas men only showed a significant reduction in hippocampal volume when carrying 2 APOE*E4 alleles. Worsening of performance on a delayed word recall task (Alzheimer's Disease Assessment Scale cognitive subscale) showed an identical pattern in association with APOE*E4 allele dose and sex. Furthermore, when controlling for memory performance on delayed word recall, the APOE*E4 effect on hippocampal volumes was attenuated in men, but remained significant in women.
Conclusion: The APOE*E4 genotype status appears to have a greater deleterious effect on gross hippocampal pathology and memory performance in women than in men.
Similar articles
-
Impact of APOE in mild cognitive impairment.Neurology. 2004 Nov 23;63(10):1898-901. doi: 10.1212/01.wnl.0000144279.21502.b7. Neurology. 2004. PMID: 15557508
-
Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.Neurology. 2001 Oct 23;57(8):1461-6. doi: 10.1212/wnl.57.8.1461. Neurology. 2001. PMID: 11673590
-
Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.Pharmacogenet Genomics. 2008 Apr;18(4):289-98. doi: 10.1097/FPC.0b013e3282f63f29. Pharmacogenet Genomics. 2008. PMID: 18334913 Clinical Trial.
-
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.Ann Neurol. 1998 Mar;43(3):303-10. doi: 10.1002/ana.410430307. Ann Neurol. 1998. PMID: 9506546 Free PMC article. Review.
-
The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease.Degener Neurol Neuromuscul Dis. 2013 Mar 2;3:11-14. doi: 10.2147/DNND.S40835. eCollection 2013. Degener Neurol Neuromuscul Dis. 2013. PMID: 30890889 Free PMC article. Review.
Cited by
-
Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.J Alzheimers Dis. 2016 Jun 18;53(3):1015-31. doi: 10.3233/JAD-160307. J Alzheimers Dis. 2016. PMID: 27340853 Free PMC article.
-
Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.Brain Pathol. 2014 Jan;24(1):33-44. doi: 10.1111/bpa.12073. Epub 2013 Jul 19. Brain Pathol. 2014. PMID: 23802663 Free PMC article.
-
A profile of brain reserve in adults at genetic risk of Alzheimer's disease.Alzheimers Dement (Amst). 2021 Jun 9;13(1):e12208. doi: 10.1002/dad2.12208. eCollection 2021. Alzheimers Dement (Amst). 2021. PMID: 34136636 Free PMC article.
-
Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice.Mol Neurodegener. 2019 Dec 20;14(1):47. doi: 10.1186/s13024-019-0352-2. Mol Neurodegener. 2019. PMID: 31861986 Free PMC article.
-
APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample.J Clin Med. 2019 Aug 16;8(8):1236. doi: 10.3390/jcm8081236. J Clin Med. 2019. PMID: 31426376 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous